Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10843	Companies
235454	Keywords
164401	Articles
126166	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 07/01/2024 at 06:50, 2 years 1 month ago

Formycon receives FDA approval for FYB203/AHZANTIVE®1) (aflibercept-mrbb), a biosimilar to Eylea®2)
Formycon receives FDA approval for FYB203/AHZANTIVE(R) (aflibercept-mrbb), a biosimilar to Eylea(R). The approval highlights Formycon's expertise and commitment to providing effective and affordable biosimilar therapies for retinal diseases.

FDA Approval Biosimilar Formycon Eylea Retinal Diseases
BRIEF

published on 06/28/2024 at 23:55, 2 years 1 month ago

FDA Approves Biosimilar FYB203/AHZANTIVE® for Retinal Diseases

FDA Approval Biosimilar Eylea Retinal Diseases Treatment Approval
BRIEF

published on 06/28/2024 at 23:55, 2 years 1 month ago

La FDA approuve le biosimilaire FYB203/AHZANTIVE® pour les maladies rétiniennes

Approbation De La FDA Biosimilaire Eylea Maladies De La Rétine Approbation Du Traitement
PRESS RELEASE

published on 06/28/2024 at 23:50, 2 years 1 month ago

EQS-Adhoc: FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)
FDA grants approval for Eylea biosimilar FYB203/AHZANTIVE by Formycon AG and Klinge Biopharma GmbH. Biosimilar approved for nAMD and other retinal diseases

FDA Approval Retinal Diseases Eylea Biosimilar FYB203/AHZANTIVE Neovascular Age-Related Macular Degeneration
BRIEF

published on 06/13/2024 at 15:35, 2 years 2 months ago

Formycon Announces AGM Results and Board Changes

Shareholders 2023 Financial Year Supervisory Board AGM Formycon
BRIEF

published on 06/13/2024 at 15:35, 2 years 2 months ago

Formycon annonce les résultats de l'AGA et les changements au conseil d'administration

Actionnaires Exercice 2023 Conseil De Surveillance AGA Formycon
PRESS RELEASE

published on 06/13/2024 at 15:30, 2 years 2 months ago

Formycon reports on the results of the Annual General Meeting
Formycon AG reports on the results of its Annual General Meeting, including approvals of agenda items, new Supervisory Board members, and election of new Chairman

Annual General Meeting Shareholders Supervisory Board Formycon AG Biosimilars
BRIEF

published on 06/13/2024 at 10:46, 2 years 2 months ago

First Berlin Equity Research Lowers Price Target for Formycon AG to €80

First Berlin Equity Research Buy Recommendation Formycon AG FYB202 Stelara
BRIEF

published on 06/13/2024 at 10:46, 2 years 2 months ago

First Berlin Equity Research abaisse son objectif de cours pour Formycon AG à 80 €

Formycon AG Recommandation D'achat FYB202 Première Recherche Sur Les Actions À Berlin Stelara
PRESS RELEASE

published on 06/13/2024 at 10:41, 2 years 2 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH reaffirms Buy recommendation for Formycon AG and lowers price target to €80 amid expected launch of lucrative biosimilar FYB202. Analyst Simon Scholes provides insights on Formycon's future prospects and market dynamics

Stock Market Analysis Buy Recommendation Formycon AG First Berlin Equity Research GmbH Biosimilar

Accesswire

Published on 08/17/2026 at 15:00, 5 hours 47 minutes ago

Norsemont Appoints Ariel Tepperman to Its Board
Published on 08/17/2026 at 14:30, 6 hours 17 minutes ago

Alset AI Completes Sale of 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/17/2026 at 14:00, 6 hours 47 minutes ago

FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at 2026 Esports World Cup
Published on 08/17/2026 at 14:00, 6 hours 47 minutes ago

Orogen Royalties and Aurum Discovery form Generative Alliance in Norway
Published on 08/17/2026 at 13:00, 7 hours 47 minutes ago

Eagle Plains Samples up to 269g/t Au at the Pine Channel Gold Project, Saskatchewan

View all ACCESSWIRE

EQS Group

Published on 08/17/2026 at 19:00, 1 hour 47 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 10 AOUT 2026 au 14 AOUT 2026
Published on 08/17/2026 at 18:50, 1 hour 57 minutes ago

Holding(s) in Company
Published on 08/17/2026 at 17:50, 2 hours 57 minutes ago

EvoNext Holdings SA confirms advanced discussions on a reverse merger with Ascend Sport Technology AG
Published on 08/17/2026 at 17:47, 3 hours ago

Key Figures 15.08.2026
Published on 08/17/2026 at 17:45, 3 hours 2 minutes ago

Press release: Information on Leonteq's shareholder base

Les Echos

Published on 08/17/2026 at 19:45, 1 hour 2 minutes ago

Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 19:45, 1 hour 2 minutes ago

Aéroports de Paris S.A - Trafic du mois de juillet 2026
Published on 08/17/2026 at 17:45, 3 hours 2 minutes ago

Weekly share buyback
Published on 08/17/2026 at 17:45, 3 hours 2 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/17/2026 at 17:40, 3 hours 7 minutes ago

Infotel : Déclaration des transactions sur actions propres réalisées du 10 au 14 août 2026 dans le cadre du programme de rachat d’actions.

View all LES ECHOS COMFI WIRE